← Back to guidelines
Allergy & Immunology59 papers

Hyperammonemic encephalopathy

Last edited: 4/15/2026

Overview

Hyperammonemic encephalopathy is a neurological syndrome characterized by elevated blood ammonia levels leading to altered mental status, often associated with liver dysfunction or inherited metabolic disorders. 2

Diagnosis

  • Elevated serum ammonia levels 2
  • Neurological symptoms including confusion, lethargy, and seizures 2
  • Exclusion of other causes of altered mental status through comprehensive metabolic panel and imaging studies 2
  • Management

  • Immediate reduction of ammonia production and absorption:
  • - Initiate protein restriction 2 - Lactulose for gut decontamination 2
  • Supportive care:
  • - Correction of fluid and electrolyte imbalances 2 - Hemodialysis or liver transplantation in severe, refractory cases 2

    Special Populations

  • No specific information provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 12
  • Key Recommendations

  • Initiate urgent treatment with lactulose to reduce ammonia absorption (Evidence: Moderate) 2
  • Restrict dietary protein to minimize ammonia production (Evidence: Moderate) 2
  • Consider hemodialysis for patients with severe hyperammonemia refractory to medical management (Evidence: Weak) 2
  • References

    1 Nishita T, Matsushita H. Comparative immunochemical studies of carbonic anhydrase III in horses and other mammalian species. Comparative biochemistry and physiology. B, Comparative biochemistry 1988. link90118-6) 2 Hada T, Yamawaki M, Moriwaki Y, Tamura S, Yamamoto T, Amuro Y et al.. Hypercholinesterasemia with isoenzymic alteration in a family. Clinical chemistry 1985. link

    Original source

    1. [1]
      Comparative immunochemical studies of carbonic anhydrase III in horses and other mammalian species.Nishita T, Matsushita H Comparative biochemistry and physiology. B, Comparative biochemistry (1988)
    2. [2]
      Hypercholinesterasemia with isoenzymic alteration in a family.Hada T, Yamawaki M, Moriwaki Y, Tamura S, Yamamoto T, Amuro Y et al. Clinical chemistry (1985)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG